II. Indications
- Low potency Intranasal Steroid for Allergic Rhinitis (age >=2 years)
III. Dosing
- Approved for age >=2 years
- As of 2022, over-ther-counter without a prescription
- Adult (and age >=12 years): 2 sprays per nostril daily (up to twice daily)
- Child (ages 2 to 11 years): 1 spray per nostril daily
IV. Safety
- Pregnancy Category C
- Unknown safety in Lactation
V. Adverse Effects
VI. Resources
VII. References
Images: Related links to external sites (from Bing)
Related Studies
| Concepts | Clinical Drug (T200) |
| SnomedCT | 407753001 |
| English | mometasone nasal, Mometasone Nasal Product, Nasal mometasone (product), Nasal mometasone |
| Spanish | mometasona nasal (producto), mometasona nasal |
Ontology: Mometasone Nasal Inhaler (C1967794)
| Concepts | Clinical Drug (T200) |
| English | Mometasone Nasal Inhaler |
